The Food and Drug Administration last week approved a new antiviral flu medication for patients aged 12 and older. While yearly vaccination is the primary means of preventing and controlling flu outbreaks, antiviral drugs can reduce flu symptoms and duration when used within 48 hours of becoming sick. “Having more treatment options that work in different ways to attack the virus is important because flu viruses can become resistant to antiviral drugs,” said Debra Birnkrant, M.D., director of the Division of Antiviral Products in the FDA’s Center for Drug Evaluation and Research.

Related News Articles

Insights and Analysis
Also in this weekly roundup of health-related news: treatment options scarce as meth deaths flare; app makes donating blood easier
Headline
In an AHA video released today for National Influenza Vaccination Week, AHA Chair Nancy Howell Agee, president and CEO of Carilion Clinic, debunks some common…
Headline
An estimated 37.1 percent of U.S. adults received a flu vaccine during the 2017-18 flu season, down from 43.3 percent during the prior flu season.
Headline
Over the last six flu seasons, getting a flu shot reduced a pregnant woman’s risk of being hospitalized from flu by an average of 40 percent, according to a…
Headline
An estimated 92 percent of hospital workers report receiving a flu vaccine for the 2017-18 flu season, compared with 75 percent of ambulatory care workers and…
Headline
The Society for Post-Acute and Long-Term Care Medicine has issued